Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working group.


Journal

Seminars in arthritis and rheumatism
ISSN: 1532-866X
Titre abrégé: Semin Arthritis Rheum
Pays: United States
ID NLM: 1306053

Informations de publication

Date de publication:
02 2023
Historique:
received: 30 03 2022
revised: 01 08 2022
accepted: 05 08 2022
pmc-release: 01 02 2024
pubmed: 22 11 2022
medline: 18 1 2023
entrez: 21 11 2022
Statut: ppublish

Résumé

Pain interference, fatigue, and impaired physical function are common features of idiopathic inflammatory myopathies (IIM). The objective of this study was to evaluate the construct validity and test-retest reliability of the Patient Reported Outcome Information System (PROMIS) Pain Interference 6av1.0, Fatigue 7av1.0, and Physical Function 8bv2.0 instruments. Patient-Reported Outcome Measures (PROMs) were deployed to adult IIM patients from OMERACT Myositis Working Group (MWG) international clinic sites via two online surveys (2019, 2021). Internal consistency of each PROM was analyzed by Cronbach's α. Construct validity was determined by a priori hypotheses generated by the MWG with >75% agreement for each hypothesis and calculated with Pearson correlations. Test-retest reliability was assessed using intraclass correlation coefficient with PROMIS instruments administered at time zero and 7 days. Surveys were sent to 368 participants in total; participants who completed each questionnaire varied (n=65 to 263). For construct validity, 10 out of 13 a priori hypotheses were met supporting construct validity of PROMIS instruments (Pain Interference 3/4, fatigue 4/4, and Physical Function 3/5). Test-retest reliability was strong for all PROMIS instruments. All PROMIS instruments demonstrated excellent internal consistency. None of the measures demonstrated any ceiling or floor effects except for a ceiling effect in the Pain Interference instrument. This study presents test-retest reliability and construct validity evidence supporting PROMIS Pain Interference (6a v1.0), Fatigue (7a v1.0), and Physical Function (8b v2.0) using a large international cohort of patients with IIM. Internal consistency of these instruments was excellent. A ceiling effect was noted in the Pain Interference instrument.

Identifiants

pubmed: 36410180
pii: S0049-0172(22)00162-7
doi: 10.1016/j.semarthrit.2022.152111
pmc: PMC10354786
mid: NIHMS1916122
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

152111

Subventions

Organisme : NIAMS NIH HHS
ID : K23 AR075898
Pays : United States
Organisme : NIAMS NIH HHS
ID : P30 AR053503
Pays : United States
Organisme : NIAMS NIH HHS
ID : P30 AR070254
Pays : United States
Organisme : NIAMS NIH HHS
ID : T32 AR048522
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no conflicts of interest.

Références

Rheumatology (Oxford). 2021 Dec 1;60(12):5713-5723
pubmed: 33714992
Rheumatol Int. 2019 Jul;39(7):1213-1220
pubmed: 31028452
Neuromuscul Disord. 2018 Jan;28(1):87-99
pubmed: 29221629
Nat Rev Dis Primers. 2021 Dec 2;7(1):86
pubmed: 34857798
Rheumatology (Oxford). 2011 Mar;50(3):578-85
pubmed: 21097879
Rheumatology (Oxford). 2005 Jan;44(1):83-8
pubmed: 15381789
PLoS One. 2015 Sep 17;10(9):e0138543
pubmed: 26379233
J Rheumatol. 2019 Jan;46(1):106-111
pubmed: 30219767
J Rheumatol. 2002 Nov;29(11):2386-92
pubmed: 12415597
Semin Arthritis Rheum. 2020 Oct;50(5):943-948
pubmed: 32906029
Turk J Emerg Med. 2018 Aug 07;18(3):91-93
pubmed: 30191186
Malawi Med J. 2012 Sep;24(3):69-71
pubmed: 23638278
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95
pubmed: 12900694
Braz J Phys Ther. 2016 Jan 19;20(2):105-13
pubmed: 26786084
Arch Phys Med Rehabil. 1987 Jul;68(7):438-41
pubmed: 3606368
Curr Rheumatol Rep. 2019 Nov 19;21(11):62
pubmed: 31741079
Rheumatology (Oxford). 2014 Apr;53(4):722-31
pubmed: 24369410
Arthritis Rheumatol. 2017 Dec;69(12):2271-2282
pubmed: 29106061
J Rheumatol. 2015 Dec;42(12):2492-5
pubmed: 25934817
J Clin Epidemiol. 2010 Nov;63(11):1179-94
pubmed: 20685078
N Engl J Med. 1975 Feb 13;292(7):344-7
pubmed: 1090839
J Rheumatol. 2014 Mar;41(3):581-92
pubmed: 24429182
Semin Arthritis Rheum. 2021 Jun;51(3):539-546
pubmed: 33894634
J Rheumatol. 2019 Oct;46(10):1351-1354
pubmed: 30770504
J Rheumatol. 2017 Nov;44(11):1683-1687
pubmed: 28765245
Semin Arthritis Rheum. 2021 Dec;51(6):1320-1330
pubmed: 34544617
Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S263-86
pubmed: 22588750

Auteurs

Dana DiRenzo (D)

Division of Rheumatology, Department of Medicine, University of Pennsylvania, USA.

Didem Saygin (D)

Division of Rheumatology, Department of Medicine, University of Chicago, USA.

Ingrid de Groot (I)

Patient Research Partner, the Netherlands.

Clifton O Bingham Iii (CO)

Division of Rheumatology, Department of Medicine, Johns Hopkins University, USA.

Ingrid E Lundberg (IE)

Division of Rheumatology, Department of Medicine, Karolinska Institutet, Karolinska University, Solna, Stockholm, Sweden.

Merrilee Needham (M)

Dept Neurology, Fiona Stanley Hospital, IIID Murdoch University and University of Notre Dame, Perth, Australia.

Jin Kyun Park (JK)

Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital and College of Medicine, Seoul, Korea.

Malin Regardt (M)

Occupational Therapist, Department of Neurobiology, Care Sciences and Society, Division of Occupational Therapy, Karolinska Institutet and Medical Unit Occupational Therapy and Physical Therapy, Karolinska University Hospital, Stockholm, Sweden.

Catherine Sarver (C)

Patient Research Partner, USA.

Yeong Wook Song (YW)

Division of Rheumatology, Department of Internal Medicine, Medical Research Center, College of Medicine, Department of Molecular Medicine and Biopharmaceutical Sciences, Seoul National University.

Lara Maxwell (L)

Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.

Dorcas Beaton (D)

Institute for Work & Health and Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.

Marianne de Visser (M)

Department of Neurology, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, the Netherlands.

Lisa Christopher-Stine (L)

Division of Rheumatology, Department of Medicine, Johns Hopkins University, USA.

Christopher A Mecoli (CA)

Division of Rheumatology, Department of Medicine, Johns Hopkins University, USA. Electronic address: cmecoli1@jhmi.edu.

Helene Alexanderson (H)

Physiotherapist, Medical Unit Occupational Therapy and Physical Therapy, Karolinska University Hospital and Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH